- Home
- CWBC vs CRVS Comparison
CWBC vs CRVS Comparison
Compare CWBC & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWBC
- CRVS
- Stock Information
- Founded
- CWBC 1989
- CRVS 2014
- Country
- CWBC United States
- CRVS United States
- Employees
- CWBC N/A
- CRVS N/A
- Industry
- CWBC Major Banks
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- CWBC Finance
- CRVS Health Care
- Exchange
- CWBC Nasdaq
- CRVS Nasdaq
- Market Cap
- CWBC 398.6M
- CRVS 459.0M
- IPO Year
- CWBC 1996
- CRVS 2016
- Fundamental
- Price
- CWBC $21.15
- CRVS $5.79
- Analyst Decision
- CWBC Buy
- CRVS Strong Buy
- Analyst Count
- CWBC 3
- CRVS 4
- Target Price
- CWBC $21.67
- CRVS $15.00
- AVG Volume (30 Days)
- CWBC 40.5K
- CRVS 547.2K
- Earning Date
- CWBC 10-23-2025
- CRVS 11-11-2025
- Dividend Yield
- CWBC 2.23%
- CRVS N/A
- EPS Growth
- CWBC 95.72
- CRVS N/A
- EPS
- CWBC 1.39
- CRVS N/A
- Revenue
- CWBC $132,829,000.00
- CRVS N/A
- Revenue This Year
- CWBC $30.64
- CRVS N/A
- Revenue Next Year
- CWBC $6.58
- CRVS N/A
- P/E Ratio
- CWBC $15.40
- CRVS N/A
- Revenue Growth
- CWBC 55.84
- CRVS N/A
- 52 Week Low
- CWBC $15.57
- CRVS $2.54
- 52 Week High
- CWBC $22.89
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- CWBC 57.85
- CRVS 56.88
- Support Level
- CWBC $20.95
- CRVS $5.64
- Resistance Level
- CWBC $21.30
- CRVS $6.09
- Average True Range (ATR)
- CWBC 0.33
- CRVS 0.34
- MACD
- CWBC -0.05
- CRVS -0.05
- Stochastic Oscillator
- CWBC 29.41
- CRVS 50.00
About CWBC Community West Bancshares
Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the Company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).